Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06348225
Other study ID # FY24-10
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date December 31, 2025

Study information

Verified date March 2024
Source Providence College
Contact Kris A Monahan, PhD
Phone 401.865.2554
Email kmonaha6@providence.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to test whether putting your legs in a hot bath after exercise improves blood pressure in people with higher blood pressure. . The main questions it aims to answer are: - Whether exercise alone, hot water leg bath alone, or both treatments together cause blood pressure to be lower during sleep. - If there are any changes in heart rhythm or blood vessel health after exercise, hot water leg bath, or the two treatments together that relate to changes in blood pressure. Participants will complete four different trials: - 30 minutes of walking with a 45-minute lukewarm leg bath after - 30 minutes of walking with a 45-minute hot leg bath after - 45 minutes of a hot leg bath with no exercise - A day with no exercise or leg bath Researchers will look at their heart rhythm, blood vessels, and blood pressure after each of these trials to see if there are differences, and if exercise and heat together can improve heart health more than exercise or heat alone.


Description:

In 2017, the American Heart Association updated standards for diagnosing hypertension, while emphasizing the need for lifestyle modification in the early stages of blood pressure elevation. Using these updated criteria, approximately 1/3 of U.S. adults have hypertension, but few are able to improve their blood pressure through diet and exercise and often progress to more severe disease states. Novel interventions to promote blood pressure reduction in mild hypertension are needed to attenuate or prevent this progression to more severe hypertension. Heat therapy, the repeated application of passive heat through hot water immersion, has gained recent attention for promising blood pressure reduction and improvement in cardiovascular health. Our preliminary work combining exercise and hot water leg immersion indicates improved overnight blood pressure in individuals with elevated blood pressure, but the magnitude and mechanisms of this improvement require further study. It is unknown whether the decrease in blood pressure following post-exercise heat exposure results from changes in systemic regulation (autonomic nervous system function, measured through heart rate variability), local factors (improved blood vessel function, measured through flow-mediated dilation), or both. The goal of the proposed research is to examine the impact of exercise alone (30 minutes of treadmill walking), hot water immersion alone (45 minutes in a leg bath set to 42°C), and combined exercise + hot water immersion (30 minutes treadmill walking followed by 45 minutes in a 42°C leg bath) on nocturnal blood pressure, autonomic function, and blood vessel function in individuals with elevated blood pressure. This goal will be addressed with the following specific aims: Aim 1. To examine the impact of exercise, hot water leg immersion, or combined exercise + hot water immersion on overnight blood pressure in individuals with elevated blood pressure. We hypothesize that the combination of exercise and hot water immersion will result in reduced systolic and diastolic blood pressure through 12 hours post-exercise as compared to baseline or either standalone treatment. Aim 2. To examine changes in autonomic function, as measured by heart rate variability (HRV) following exercise, leg heating, or combined therapies. We hypothesize that combined exercise and hot water immersion will result in higher HRV (indicating improved autonomic balance) compared to baseline measures. Aim 3. To examine changes in blood vessel (endothelial) function, measured using flow-mediated dilation, following exercise, leg heating, or combined therapies. We hypothesize that combined exercise and hot water immersion will result in a higher flow-mediated dilation (indicating improved blood vessel relaxation) compared to baseline or either standalone intervention. The results of this study have important health implications in the treatment of hypertension using lifestyle interventions for the millions of Americans with elevated blood pressure or hypertension. The findings have the potential to improve non-pharmacological treatment of hypertension by developing an exercise and heat exposure protocol that is cost-effective, easily implemented, and results in substantially reduced blood pressure and improved cardiovascular risk profile.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - resting blood pressure >120/80 mmHg; measured at screening visit - BMI between 18-39.9 - capable of walking 30 min at a moderate intensity on a treadmill Exclusion Criteria: - diagnosed hypertension - taking antihypertensive medications - history of heat injury or heat illness

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise or heat treatment
Interventions will be each of the four arms described previously, administered ~1 week apart in a randomized, counter-balanced fashion.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Providence College

Outcome

Type Measure Description Time frame Safety issue
Primary Ambulatory blood pressure Welch-Allyn ambulatory blood pressure monitor placed on the arm after treatment 24 hours post-treatment
Primary Heart Rate Variability 3-lead ECG with paced breathing measured post-treatment 30-60 min post-treatment
Primary Flow-mediated dilation Measure of endothelial function in the brachial artery (arm), change in blood vessel diameter following a 5-minute blood flow occlusion and release 30-60 min post-treatment
See also
  Status Clinical Trial Phase
Completed NCT03626363 - Mindfulness and Neural Cardiovascular Control in Humans N/A
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT04953650 - Intermittent Fasting Towards Elevated Blood Pressure N/A
Enrolling by invitation NCT06033417 - Walking and Blood Pressure in Older Adults With Respiratory Impairment. N/A
Completed NCT03716960 - The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women. N/A
Completed NCT05533268 - Effect of Mental and Physical Training on Blood Pressure N/A
Completed NCT05029427 - Effect of Oat Beta Glucan in Managing Blood Pressure N/A
Recruiting NCT05370625 - To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure N/A
Not yet recruiting NCT06376812 - No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women N/A
Active, not recruiting NCT04766424 - Sleep Technology Intervention to Target Cardiometabolic Health N/A
Recruiting NCT05297708 - Office, Home, and Ambulatory Blood Pressure
Completed NCT00869193 - Effect of Grape Seed Extract on Blood Pressure N/A
Completed NCT04298944 - Association of Mood With Risk for Atherosclerosis
Recruiting NCT05397535 - Baduanjin Lower Elevated Blood PreSsure Study N/A
Completed NCT05928676 - Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure N/A
Not yet recruiting NCT03764020 - Trial of Oral Melatonin in Elevated Blood Pressure Phase 3
Suspended NCT03508739 - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition Phase 3
Active, not recruiting NCT05469503 - Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure N/A
Recruiting NCT05955040 - Treatment of Elevated Blood Pressures in Early Pregnancy Phase 2